Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 20 Squamous Cell Carcinoma of Head and Neck 3 Small Cell Lung Carcinoma 2 Retinoblastoma 2 Lung Neoplasms 2 Esophageal Neoplasms 2 Uterine Cervical Neoplasms 1 Sjogren's Syndrome 1 Scleroderma, Systemic 1 Retinal Neoplasms 1 Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC) 1 Recurrence 1 Psoriasis 1 Ovarian Neoplasms 1 Ovarian Cancer Recurrent 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 NSCLC 1 Multiple Sclerosis 1 Melanoma 1 Lymphatic Metastasis 1 Lupus Erythematosus, Systemic 1 Inflammatory Bowel Diseases 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Dermatomyositis 1 Crohn Disease 1 Colorectal Neoplasms 1

Interventions

Paclitaxel 69 Bevacizumab 62 Carboplatin 53 pembrolizumab 46 olaparib 32 Specimen Handling 27 Gemcitabine 27 Cyclophosphamide 26 Magnetic Resonance Spectroscopy 24 liposomal doxorubicin 22 Cisplatin 21 niraparib 20 Taxes 18 Nivolumab 18 fludarabine 17 Topotecan 17 Biopsy 17 Doxorubicin 14 Immunoglobulin G 12 Fulvestrant 12 Disulfides 12 Oxaliplatin 10 mirvetuximab soravtansine 9 durvalumab 9 aldesleukin 9 Surveys and Questionnaires 9 Ipilimumab 9 Fluorouracil 9 Blood Specimen Collection 9 cemiplimab 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Ovarian Neoplasms × Platinum Compounds × 1 year × Clear all

NCT07340164 2026-04-20

TROY

Yonsei University

Phase 2 Recruiting

Ovarian Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡